PureTech Health (PRTC) Investor Presentation - Slideshow

Our Distinctive Approach Drives Success PureTech's Proven Expertise 8 1 References in this presentation to "Wholly Owned Programs" refer to the Company's six therapeutic candidates (LYT-100, LYT-200, LYT-300, LYT-310, LYT-510, and LYT-503/IMB-150), lymphatic and inflammation platforms and potential future therapeutic candidates and platforms that the Company may develop or obtain. References to "Wholly Owned Pipeline" refer to LYT-100, LYT-200, LYT-300, LYT-310, LYT-510, and LYT-503/IMB-150. On July 23, 202 ...